Skip to main content

Lupin's generic Clarinex gets FDA approval

11/3/2010

SILVER SPRING, Md. The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for allergies, according to FDA records.


 


The drug is a generic version of Schering-Plough’s Clarinex.


 


 


Clarinex has annual sales of around $229 million, according to IMS Health data reported by several media in India, where Lupin is based.


 


X
This ad will auto-close in 10 seconds